Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 176   

Articles published

GSK 1,471.38 -10.12 (-0.68%)
price chart
Deutsche Bank Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (ADR) logo Deutsche Bank reaffirmed their hold rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report released on Wednesday.
GlaxoSmithKline plc Price Target Lowered to GBX 1540 at Berenberg Bank (GSK)  Watch List News (press release)
Related articles »  
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK)
GlaxoSmithKline plc (ADR) logo JPMorgan Chase & Co. restated their neutral rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report issued on Tuesday. JPMorgan Chase & Co. has also taken action a number of other healthcare stocks recently.
GlaxoSmithKline plc Receives Underperform Rating from Credit Suisse (GSK)  The Legacy
Related articles »  
Most Traded EZU: Unilever NV (UN), GlaxoSmithKline plc (GSK), Loews ...
GlaxoSmithKline plc (GSK) of the Healthcare sector (Drug Manufacturers - Major) has lost -0.24% from open per share at mid-day today.
Related articles »  
GlaxoSmithKline plc Receives Consensus Rating of "Hold" from Analysts (NYSE ...
GlaxoSmithKline plc (NYSE:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related ...
Related articles »  
Healthcare Sector Movers: Teva Pharmaceutical Industries Limited (TEVA ...
GlaxoSmithKline plc (GSK) of the Healthcare sector (Drug Manufacturers - Major) moved by -0.17% since open at mid-day today.
Related articles »  
Why Making Dramatic Moves: GlaxoSmithKline plc (NYSE:GSK), Alcatel Lucent ...
Credit Suisse reiterated their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note released on Wednesday morning.
Related articles »  
Why Making Dramatic Moves: GlaxoSmithKline plc (NYSE:GSK), Nokia ...
GlaxoSmithKline plc (NYSE:GSK) last released its earnings data on Wednesday, October 22nd. The company reported $0.90 earnings per share for the quarter, beating the analysts' consensus estimate of $0.79 by $0.11.
GlaxoSmithKline plc Receives "Neutral" Rating from JPMorgan Chase & Co. (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its ´┐Żneutral´┐Ż rating reissued by equities researchers at JPMorgan Chase & Co.
JPMorgan Chase & Co. Reiterates Neutral Rating for GlaxoSmithKline plc (GSK)
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily ...
GlaxoSmithKline plc To Go Ex-Dividend on November 6th (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) declared a dividend on Wednesday, October 22nd, American Banking News.
GlaxoSmithKline plc's Neutral Rating Reaffirmed at JPMorgan Chase & ...  Ticker Report
JPMorgan Chase & Co. Reaffirms Neutral Rating for GlaxoSmithKline plc (GSK)  sleekmoney
Related articles »